Multiple Sclerosis Immunotherapy Pill Launch
This is a England news story, published by Guardian, that relates primarily to MS news.
England news
For more England news, you can click here:
more England newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
multiple sclerosis. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest immunotherapy pill news, MS news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
active multiple sclerosisGuardian
•Health
Health
NHS England first in Europe to roll out take-at-home pill for MS patients

70% Informative
Current treatments involve regular trips to hospital, drug infusions, frequent injections and monitoring.
New tablet, cladribine, can be swallowed at home, and needs to be taken only 20 times in the first two years of a four-year cycle.
NHS in England is the first healthcare system in Europe to widely introduce the drug to patients with active relapsing-remitting MS .
VR Score
75
Informative language
80
Neutral language
19
Article tone
formal
Language
English
Language complexity
64
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links